Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-12 Purchase |
2024-02-13 5:48 pm |
Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner |
910,000 | $22 | $20,020,000 | 4,126,119 (Direct) |
View |
| 2024-01-29 Purchase |
2024-01-31 5:00 pm |
Arcus Biosciences Inc. | RCUS | GILEAD SCIENCES INC. 10% Owner |
15,238,095 | $21 | $319,999,995 | 30,061,124 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 6:01 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
5,000 | $85.78 | $428,900 | 101,534 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 3:58 pm |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
8,242 | $85.23 | $702,466 | 82,729 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-18 4:31 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
5,000 | $80 | $400,017 | 104,003 (Direct) |
View |
| 2023-09-12 Sale |
2023-09-13 6:50 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
1,501 | $76.99 | $115,562 | 70,130 (Direct) |
View |
| 2023-07-20 Sale |
2023-07-21 5:30 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
5,000 | $80 | $400,000 | 107,587 (Direct) |
View |
| 2023-06-28 Purchase |
2023-06-30 3:12 pm |
Arcus Biosciences Inc. | RCUS | GILEAD SCIENCES INC. 10% Owner |
1,010,000 | $19.26 | $19,452,600 | 14,823,029 (Direct) |
View |
| 2023-06-27 Purchase |
2023-06-28 5:17 pm |
Allovir Inc. | ALVR | GILEAD SCIENCES INC. 10% Owner |
2,930,870 | $3.75 | $10,990,763 | 16,635,286 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-14 5:48 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
1,485 | $76.9 | $114,197 | 29,402 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-12 Conversion |
2024-02-13 5:48 pm |
N/A N/A |
Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner |
17,853,002 | $0 | 4,126,119 (Direct) |
View |
Ownership |
2024-02-07 5:35 pm |
N/A N/A |
Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 3,216,119 (Direct) |
View |
| 2024-02-02 Option Award |
2024-02-06 6:01 pm |
N/A 2034-02-02 |
GILEAD SCIENCES INC. | GILD | LOVE TED W Director |
3,508 | $0 | 3,508 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 2:42 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
76,853 | $0 | 102,616 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 2:42 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
23,709 | $78.26 | 102,616 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 2:34 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
74,055 | $0 | 113,147 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 2:34 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
22,509 | $78.26 | 113,147 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 2:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
4,646 | $0 | 11,728 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 2:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
74,961 | $0 | 129,436 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 2:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
23,410 | $78.26 | 129,436 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 1:40 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
230,747 | $0 | 468,689 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 1:40 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
79,335 | $78.26 | 468,689 (Direct) |
View |
| 2024-01-25 Tax Withholding |
2024-01-26 4:31 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
194 | $80.23 | 38,905 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-26 4:31 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
514 | $0 | 38,905 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 4:36 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director |
30 | $0 | 3,224 (Direct) |
View |
Ownership |
2023-12-28 5:09 pm |
N/A N/A |
Arcellx Inc. | ACLX | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 6,720,803 (Direct) |
View |
Ownership |
2023-12-22 4:07 pm |
N/A N/A |
HOOKIPA Pharma Inc. | HOOK | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 18,759,465 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
1,247 | $79.02 | 130,958 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
2,730 | $0 | 130,958 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
1,269 | $79.02 | 112,615 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
2,779 | $0 | 112,615 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
222 | $79.02 | 46,940 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
518 | $0 | 46,940 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:04 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
3,341 | $79.02 | 498,583 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:04 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
7,347 | $0 | 498,583 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:00 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,194 | $79.02 | 145,368 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:00 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,617 | $0 | 145,368 (Direct) |
View |
| 2023-11-10 Exercise |
2023-11-13 6:21 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,912 | $0 | 146,562 (Direct) |
View |
| 2023-11-10 Tax Withholding |
2023-11-13 6:21 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
804 | $75.92 | 146,562 (Direct) |
View |
| 2023-10-25 Tax Withholding |
2023-10-26 5:56 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
243 | $78.39 | 39,099 (Direct) |
View |
| 2023-10-25 Exercise |
2023-10-26 5:56 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
514 | $0 | 39,099 (Direct) |
View |
Ownership |
2023-10-25 7:15 pm |
N/A N/A |
ASSEMBLY BIOSCIENCES INC. | ASMB | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 13,073,668 (Direct) |
View |
| 2023-09-28 Option Award |
2023-09-29 8:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director |
31 | $0 | 3,195 (Direct) |
View |
| 2023-09-10 Tax Withholding |
2023-09-11 8:44 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
1,256 | $76 | 132,205 (Direct) |
View |
| 2023-09-10 Exercise |
2023-09-11 8:44 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
2,730 | $0 | 132,205 (Direct) |
View |
| 2023-09-10 Tax Withholding |
2023-09-11 8:40 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,203 | $76 | 152,366 (Direct) |
View |
| 2023-09-10 Exercise |
2023-09-11 8:40 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,619 | $0 | 152,366 (Direct) |
View |
| 2023-09-10 Tax Withholding |
2023-09-11 8:37 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
149 | $76 | 47,162 (Direct) |
View |
| 2023-09-10 Exercise |
2023-09-11 8:37 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
519 | $0 | 47,162 (Direct) |
View |
| 2023-09-10 Tax Withholding |
2023-09-11 8:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
1,278 | $76 | 115,385 (Direct) |
View |
| 2023-09-10 Exercise |
2023-09-11 8:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
2,779 | $0 | 115,385 (Direct) |
View |
| 2023-09-10 Tax Withholding |
2023-09-11 8:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
3,366 | $76 | 501,924 (Direct) |
View |
| 2023-09-10 Exercise |
2023-09-11 8:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
7,348 | $0 | 501,924 (Direct) |
View |
| 2023-08-10 Tax Withholding |
2023-08-11 4:36 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
1,306 | $80 | 47,311 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-11 4:36 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
4,484 | $0 | 47,311 (Direct) |
View |
| 2023-07-25 Exercise |
2023-07-26 4:53 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
10,289 | $0 | 74,251 (Direct) |
View |
| 2023-07-25 Tax Withholding |
2023-07-26 4:53 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
4,174 | $77.23 | 74,251 (Direct) |
View |
| 2023-07-24 Exercise |
2023-07-25 6:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
7,505 | $0 | 93,773 (Direct) |
View |
| 2023-07-24 Tax Withholding |
2023-07-25 6:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
3,174 | $77.66 | 93,773 (Direct) |
View |
| 2023-06-29 Option Award |
2023-06-30 3:54 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director |
31 | $0 | 3,163 (Direct) |
View |